Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease
乌帕替尼的获益风险比:对中重度活动性溃疡性结肠炎或克罗恩病患者的 2b/3 期研究进行探索性事后分析
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf198
Vermeire, Severine; Colombel, Jean-Frederic; Danese, Silvio; Panaccione, Remo; Peyrin-Biroulet, Laurent; Beck, Kendall; Chaparro, María; Gisbert, Javier P; Dubcenco, Elena; Klaff, Justin; Naling, Grace; Ford, Sharanya; Remple, Valencia; Joshi, Namita; Suravaram, Smitha; Duncan, Benjamin; Wang, Yibo; Wick-Urban, Bettina; Loftus, Edward V